John Hester
Stock Analyst at Bell Potter
(3.04)
# 2,660
Out of 5,125 analysts
233
Total ratings
41%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $4.40 → $4.20 | $2.03 | +106.90% | 25 | Nov 1, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Downgraded: Hold | $3.00 | $2.91 | +3.09% | 7 | Oct 19, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $1.09 | $0.50 | +120.20% | 8 | Oct 6, 2026 | |
| ASX: EIQ Echo IQ Limited | Reiterated: Sell | $0.30 | $0.54 | -43.93% | 5 | Sep 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $19.00 | $14.02 | +35.52% | 35 | Sep 21, 2026 | |
| ASX: 4DX 4DMedical Limited | Reiterated: Buy | $6.00 | $2.37 | +153.16% | 14 | Aug 30, 2026 | |
| ASX: PNV PolyNovo Limited | Upgraded: Buy | $1.00 → $1.22 | $0.91 | +34.81% | 13 | Aug 28, 2026 | |
| ASX: PGC Paragon Care Limited | Reiterated: Hold | $0.17 → $0.16 | $0.16 | - | 18 | Aug 27, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Hold | $3.60 → $3.20 | $2.78 | +15.11% | 17 | Aug 26, 2026 | |
| ASX: CYC Cyclopharm Limited | Reiterated: Buy | $1.00 | $0.46 | +117.39% | 15 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $226.00 | $207.31 | +9.02% | 16 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.24 → $0.22 | $0.13 | +76.00% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13.00 | $8.50 | +52.94% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.50 → $6.40 | $1.66 | +285.54% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.45 → $0.42 | $0.25 | +71.43% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.25 | $0.03 | +635.29% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.05 → $0.06 | $0.00 | +1,400.00% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.02 | n/a | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.00 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.96 → $3.92 | $4.52 | n/a | 3 | Nov 25, 2022 |
Mesoblast Limited
Nov 1, 2026
Reiterated: Buy
Price Target: $4.40 → $4.20
Current: $2.03
Upside: +106.90%
Sigma Healthcare Limited
Oct 19, 2026
Downgraded: Hold
Price Target: $3.00
Current: $2.91
Upside: +3.09%
Aroa Biosurgery Limited
Oct 6, 2026
Reiterated: Buy
Price Target: $1.09
Current: $0.50
Upside: +120.20%
Echo IQ Limited
Sep 22, 2026
Reiterated: Sell
Price Target: $0.30
Current: $0.54
Upside: -43.93%
Telix Pharmaceuticals Limited
Sep 21, 2026
Reiterated: Buy
Price Target: $19.00
Current: $14.02
Upside: +35.52%
4DMedical Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $6.00
Current: $2.37
Upside: +153.16%
PolyNovo Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $1.00 → $1.22
Current: $0.91
Upside: +34.81%
Paragon Care Limited
Aug 27, 2026
Reiterated: Hold
Price Target: $0.17 → $0.16
Current: $0.16
Upside: -
Nanosonics Limited
Aug 26, 2026
Reiterated: Hold
Price Target: $3.60 → $3.20
Current: $2.78
Upside: +15.11%
Cyclopharm Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.46
Upside: +117.39%
Aug 19, 2026
Reiterated: Buy
Price Target: $226.00
Current: $207.31
Upside: +9.02%
Aug 18, 2026
Reiterated: Buy
Price Target: $0.24 → $0.22
Current: $0.13
Upside: +76.00%
Aug 12, 2026
Downgraded: Hold
Price Target: $13.00
Current: $8.50
Upside: +52.94%
Aug 10, 2026
Reiterated: Buy
Price Target: $6.50 → $6.40
Current: $1.66
Upside: +285.54%
Aug 3, 2026
Reiterated: Buy
Price Target: $0.45 → $0.42
Current: $0.25
Upside: +71.43%
May 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.03
Upside: +635.29%
Dec 17, 2025
Reiterated: Buy
Price Target: $0.05 → $0.06
Current: $0.00
Upside: +1,400.00%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.02
Upside: n/a
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.00
Upside: n/a
Nov 25, 2022
Reiterated: Hold
Price Target: $4.96 → $3.92
Current: $4.52
Upside: n/a